Just opened a Stocks and Shares ISA? Here are 10 stocks to consider buying, according to AI

The Â£20,000 annual allowance of Stocks and Shares ISAs across Britain has just been reset. And with the start of a new tax year, many new investors are entering the market as economic conditions slowly improve and savings rates fall.

One of the biggest challenges investors face is building a well-balanced portfolio. But with artificial intelligence (AI) models constantly getting smarter, why not outsource this task to ChatGPT?

After tasking the chatbot to build an ISA portfolio, it made 10 recommendations. And some of the suggestions actually look like decent foundational stocks. However, ChatGPT also made some pretty risky and volatile suggestions. In fact, the model doesn’t appear to have taken risk tolerance into account at all.

Building a balanced ISA

The list of stocks that ChatGPT recommended is:

AstraZeneca (LSE:AZN)
Apple
Microsoft
Tesla
Unilever
Diageo
Shell
Johnson & Johnson
NextEra Energy
Ãrsted

The portfolio offers exposure to a variety of industries, such as beverages, pharmaceuticals, consumer staples, energy, technology, and automotive. What’s more, half of the companies are listed outside of the UK, with operations spanning the globe, offering even more geographical diversification benefits.

The businesses themselves are also well-known industry titans, with large market capitalisations and deep financial pockets that reduce the risk of bankruptcy. And with some touting a long history of paying dividends, this portfolio offers a nice blend of both growth and income investments.

Overall, everything appears to be in place. So what’s wrong with this ISA portfolio?

Understanding risk

Despite the large scale of these businesses, several of ChatGPT’s suggestions are pretty risky stock picks. For example, Tesla has recently seen almost half of its market-cap wiped out in just the last few months, Diageo has been on a similar decline since 2022, as has Ãrsted.

Of course, not all of these companies are on a downward trajectory. AstraZeneca is one of these exceptions, and the pharma giant’s steady stream of successful clinical trial results has propelled the stock price higher. In fact, it’s now the largest enterprise on the entire London Stock Exchange.

Sadly, that still doesn’t make it a risk-free investment. Clinical trials are notoriously challenging and expensive to execute. And just because it’s been enjoying successes recently doesn’t mean it will continue to do so. In fact, the company has experienced many painful clinical trial failures over the years.

Case in point, in 2017, its phase-three MYSTIC trial failed in the final home stretch, resulting in the AstraZeneca share price collapsing by over 15% in a single day.

In other words, investing in pharmaceuticals can be a volatile journey, even among the biggest names, such as AstraZeneca and Johnson & Johnson.

The bottom line

Every one of ChatGPT’s recommended ISA stocks has its risks, some bigger than others. Diversification can help take some of the sting away. But it’s still paramount that investors dig into the details to understand exactly what sort of investments they are making and whether they fit within their risk tolerance limits.

The post Just opened a Stocks and Shares ISA? Here are 10 stocks to consider buying, according to AI appeared first on The Motley Fool UK.

5 Shares for the Future of Energy

Investors who don’t own energy shares need to see this now.

Because Mark Rogers — The Motley Fool UK’s Director of Investing — sees 2 key reasons why energy is set to soar.

While sanctions slam Russian supplies, nations are also racing to achieve net zero emissions, he says. Mark believes 5 companies in particular are poised for spectacular profits.

Open this new report — 5 Shares for the Future of Energy — and discover:

Britain’s Energy Fort Knox, now controlling 30% of UK energy storage
How to potentially get paid by the weather
Electric Vehicles’ secret backdoor opportunity
One dead simple stock for the new nuclear boom

Click the button below to find out how you can get your hands on the full report now, and as a thank you for your interest, we’ll send you one of the five picks — absolutely free!

Grab your FREE Energy recommendation now

More reading

Zaven Boyrazian has no position in any of the shares mentioned. The Motley Fool UK has recommended Apple, AstraZeneca Plc, Diageo Plc, Microsoft, Tesla, and Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.